サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423559

下肢静脈瘤治療市場の2030年までの予測：製品タイプ別、エンドユーザー別、地域別の世界分析

Varicose Vein Treatment Market Forecasts to 2030 - Global Analysis By Product, Treatment Type, End User and By Geography

出版日
ページ情報
英文 200+ Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
下肢静脈瘤治療市場の2030年までの予測：製品タイプ別、エンドユーザー別、地域別の世界分析
出版日: 2024年02月02日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界の下肢静脈瘤治療市場は、2023年に14億米ドルを占め、予測期間中にCAGR 8.3％で成長し、2030年までに24億米ドルに達すると予想されています。

下肢静脈瘤治療は、下肢静脈瘤に関連する症状への対処と緩和を目的とした医療介入を含みます。下肢静脈瘤は、一般的に下肢に現れる拡大したねじれた静脈であり、静脈壁や弁の弱体化または損傷に起因します。定期的な運動、健康的な体重の維持、脚を高くするなどの生活習慣の改善は、これらの医学的介入を補完することができます。

患者の意識の高まり

患者は現在、タイムリーな診断のためにヘルスケア専門家に相談し、生活習慣の改善から低侵襲手術まで、利用可能な治療法を探ることに積極的になっています。このような意識の高まりは、静脈不全や潰瘍といった未治療の静脈瘤がもたらす医学的影響と、静脈が見えることに伴う美容上の懸念の両方に及んでいます。さらに、予防ヘルスケアと早期介入に重点を置くことで、静脈の問題に迅速に対処することが奨励され、下肢静脈瘤治療市場に好影響を与えています。

高コスト

静脈瘤の重症度や根本的な原因を評価するために必要な超音波画像診断などの診断検査は、専門的な機器、熟練した医療専門家、複数回のセッションを必要とする場合があり、コスト高につながります。保険の適用範囲や償還方針も、静脈瘤治療の経済性に影響を与える可能性があります。さらに、高額な治療費は低所得者や保険適用が不十分な個人に不釣り合いな影響を及ぼし、医療へのアクセスと治療結果の格差につながり、この市場規模の妨げとなっています。

ヘルスケア・インフラの改善

静脈瘤専門クリニックの設立や最新機器の利用可能性など、医療施設の進歩は、静脈瘤患者に対するアクセスの向上と治療の質の向上に寄与しています。これらの施設は最新技術を統合し、厳格な医療基準を遵守しているため、患者はより安全で効果的な治療の恩恵を受けることができます。さらに、静脈疾患を専門とする熟練した医療専門家の存在がインフラをさらに強化し、この市場の拡大を後押ししています。

認識不足

自覚症状の欠如は診断や介入の遅れの一因であり、患者は症状が重篤化するまで医療機関に相談しないことがあります。公衆教育の取り組みがなく、静脈瘤と利用可能な治療法に関する情報の普及が限られていることが、この課題をさらに悪化させています。さらに、その結果、人口のかなりの部分が早期介入の重要性について知らされていないままであるため、この市場の妨げとなっています。

COVID-19の影響

COVID-19の大流行は下肢静脈瘤治療市場にいくつかの点でマイナスの影響を与えています。医療施設の閉鎖、不要不急の医療処置の制限、医療資源のパンデミック関連活動への再配分により、下肢静脈瘤治療を含む選択的処置の件数が大幅に減少しました。さらに、パンデミック期間中の経済的不確実性と財政的制約が医療支出の減少を招き、この市場規模の妨げとなった。

予測期間中、静脈閉鎖製品分野が最大となる見込み

静脈閉鎖製品分野は、静脈不全や静脈瘤に対処するために、罹患した静脈を閉鎖または密封するように設計された医療機器の範囲により、最大のシェアを占めると推定されます。これらの製品は、血流をより健康的な静脈に振り向けることを目的とした低侵襲治療において重要な役割を果たしています。さらに、これらの静脈閉鎖製品は、患者に従来の外科的アプローチに代わる効果的な選択肢を提供する低侵襲的介入の増加傾向に貢献しており、このセグメントの拡大を後押ししています。

注射硬化療法分野は予測期間中に最も高いCAGRが見込まれる

注射硬化療法分野は、予測期間中にCAGRが最も高くなると予測されています。この技術では、硬化溶液を罹患静脈に直接注入し、静脈を崩壊させ、最終的に体内に吸収させる。これは特に小さな静脈瘤やクモ状静脈に効果的です。さらに、注射硬化療法は、その簡便さ、手頃な価格、外来患者という性質から好まれることが多く、患者と医療提供者の両方にとって人気のある選択肢となっており、このセグメントの拡大を牽引しています。

最大シェアの地域

アジア太平洋地域は、人口の高齢化、ライフスタイルの変化、認知度の向上などの要因により、予測期間中に最大の市場シェアを占めました。Medtronic PLC、Alma Lasers Ltd.、Teleflex Incorporated、Boston Scientificなどの主要企業は、静脈内レーザー治療（EVLT）、ラジオ波焼灼療法（RFA）、注射硬化療法などの低侵襲手技を採用しています。さらに、ヘルスケアシステムが進化し続け、より低侵襲で効果的な治療に対する需要が持続していることから、この市場はさらに拡大するものと思われます。

CAGRが最も高い地域：

欧州は、静脈の健康に対する意識の高まりにより、予測期間中に最も高いCAGRを記録すると予想されます。これは静脈内レーザー治療（EVLT）、ラジオ波焼灼療法（RFA）、注射硬化療法などの低侵襲手技への動向を反映しています。さらに、欧州の患者は回復時間の短い外来の選択肢を求めるようになっており、こうした侵襲性の低い手技の人気がこの地域の成長を後押ししています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の下肢静脈瘤治療市場：製品別

  • 静脈閉鎖製品
  • アブレーション装置
    • 高周波アブレーション装置
    • レーザーアブレーション装置
  • 外科手術用製品
  • その他の製品

第6章 世界の下肢静脈瘤治療市場：治療タイプ別

  • 外科的結紮/ストリッピング
  • 静脈内アブレーション
  • 注射硬化療法
  • その他の治療タイプ

第7章 世界の下肢静脈瘤治療市場：エンドユーザー別

  • 静脈クリニック
  • 外来診療ユニット
  • 病院
  • その他のエンドユーザー

第8章 世界の静脈瘤治療市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイル

  • Medtronic PLC
  • Dornier MedTech GmbH
  • Candela Medical
  • Won Tech Co. Ltd
  • Boston Scientific
  • Sciton Inc.
  • El. En SpA Group
  • Alma Lasers Ltd
  • Teleflex Incorporated
  • AngioDynamics Inc.
  • Eufoton SRL
  • Biolitec AG
図表

List of Tables

  • Table 1 Global Varicose Vein Treatment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 4 Global Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 5 Global Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 6 Global Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 7 Global Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 8 Global Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 10 Global Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 8 Global Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 9 Global Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 10 Global Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 14 Global Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 15 Global Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 16 Global Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 17 Global Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 18 Global Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 19 North America Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 20 North America Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 21 North America Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 22 North America Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 23 North America Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 24 North America Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 25 North America Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 26 North America Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 27 North America Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 28 North America Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 29 North America Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 30 North America Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 31 North America Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 32 North America Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 North America Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 34 North America Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 35 North America Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 North America Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 39 Asia Pacific Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 40 Asia Pacific Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 41 Asia Pacific Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 42 Asia Pacific Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 43 Asia Pacific Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 44 Asia Pacific Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 45 Asia Pacific Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 46 Asia Pacific Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 47 Asia Pacific Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 48 Asia Pacific Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 49 Asia Pacific Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 50 Asia Pacific Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 51 Asia Pacific Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 52 Asia Pacific Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 53 Asia Pacific Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 54 Asia Pacific Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 55 Europe Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 56 Europe Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 57 Europe Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 58 Europe Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 59 Europe Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 60 Europe Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 61 Europe Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 62 Europe Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 63 Europe Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 64 Europe Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 65 Europe Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 66 Europe Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 67 Europe Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 68 Europe Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Europe Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 70 Europe Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 71 Europe Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Europe Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 South America Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 South America Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 South America Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 76 South America Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 77 South America Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 78 South America Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 79 South America Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 80 South America Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 81 South America Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 82 South America Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 83 South America Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 84 South America Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 85 South America Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 86 South America Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 87 South America Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 88 South America Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 89 South America Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 90 South America Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 91 Middle East & Africa Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 92 Middle East & Africa Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 93 Middle East & Africa Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 94 Middle East & Africa Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 95 Middle East & Africa Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 96 Middle East & Africa Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 97 Middle East & Africa Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 98 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 99 Middle East & Africa Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 100 Middle East & Africa Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 101 Middle East & Africa Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 102 Middle East & Africa Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 103 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 104 Middle East & Africa Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 105 Middle East & Africa Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 106 Middle East & Africa Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 107 Middle East & Africa Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 108 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC24793

According to Stratistics MRC, the Global Varicose Vein Treatment Market is accounted for $1.4 billion in 2023 and is expected to reach $2.4 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Varicose vein treatment involves medical interventions aimed at addressing and alleviating the symptoms associated with varicose veins. Varicose veins are enlarged, twisted veins that commonly appear in the legs and result from weakened or damaged vein walls and valves. Lifestyle modifications, such as regular exercise, maintaining a healthy weight, and elevating the legs, can complement these medical interventions.

Market Dynamics:

Driver:

Rising patient awareness

Patients are now more proactive in consulting healthcare professionals for timely diagnosis and exploring available treatment modalities, ranging from lifestyle modifications to minimally invasive procedures. This heightened awareness extends to both the medical implications of untreated varicose veins, such as venous insufficiency and ulceration, and the aesthetic concerns associated with visible veins. Furthermore, the emphasis on preventive healthcare and early intervention has encouraged individuals to address venous issues promptly, fostering a positive impact on the varicose vein treatment market.

Restraint:

High cost

Diagnostic tests such as ultrasound imaging, which are necessary to assess the severity and underlying causes of varicose veins, may require specialized equipment, skilled healthcare professionals, and multiple sessions, leading to higher costs. Insurance coverage and reimbursement policies can also impact the affordability of varicose vein treatment. Moreover, the high cost of treatment can disproportionately affect individuals with lower incomes or inadequate insurance coverage, leading to disparities in healthcare access and outcomes, which is hampering this market size.

Opportunity:

Improving healthcare infrastructure

Advances in medical facilities, including the establishment of specialized vein clinics and the availability of state-of-the-art equipment, contribute to enhanced accessibility and quality of care for individuals with varicose veins. As these facilities integrate modern technologies and adhere to stringent medical standards, patients benefit from safer and more effective interventions. Additionally, the presence of skilled healthcare professionals specializing in venous disorders further strengthens the infrastructure, which is propelling this market's expansion.

Threat:

Lack of awareness

The lack of awareness contributes to delayed diagnosis and intervention, as patients may not seek medical advice until symptoms become severe. The absence of public education initiatives and the limited dissemination of information about varicose veins and available treatment options further exacerbate this challenge. Moreover, as a result, a substantial portion of the population remains uninformed about the importance of early intervention, thereby hindering this market.

Covid-19 Impact

The COVID-19 pandemic has negatively impacted the varicose vein treatment market in several ways. Lockdowns, restrictions on non-essential medical procedures, and the reallocation of healthcare resources to pandemic-related activities led to a significant decline in the number of elective procedures, including varicose vein treatments. Additionally, economic uncertainties and financial constraints during the pandemic resulted in reduced healthcare spending, thereby hampering this market size.

The venous closure products segment is expected to be the largest during the forecast period

The venous closure products segment is estimated to hold the largest share due to a range of medical devices designed to address venous insufficiency and varicose veins by closing or sealing affected veins. These products play a crucial role in minimally invasive treatments that aim to redirect blood flow to healthier veins. Further, these venous closure products contribute to the growing trend of minimally invasive interventions, providing patients with effective alternatives to traditional surgical approaches, which is boosting this segment's expansion.

The injection sclerotherapy segment is expected to have the highest CAGR during the forecast period

The injection sclerotherapy segment is anticipated to have highest CAGR during the forecast period. This technique involves injecting a sclerosing solution directly into the affected veins, causing them to collapse and eventually be absorbed by the body. It is particularly effective for smaller varicose veins and spider veins. Furthermore, injection sclerotherapy is often preferred for its simplicity, affordability, and outpatient nature, making it a popular choice for both patients and healthcare providers, driving this segment's expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to factors such as population aging, lifestyle changes, and increasing awareness. Key players such as Medtronic PLC, Alma Lasers Ltd., Teleflex Incorporated, and Boston Scientific are adopting minimally invasive procedures like endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and injection sclerotherapy. In addition, as healthcare systems continue to evolve and the demand for effective, less-invasive interventions persists, this market is poised for further expansion.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to growing awareness of venous health. It reflects a trend toward minimally invasive procedures, such as endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and injection sclerotherapy. Moreover, patients in Europe are increasingly seeking outpatient options with shorter recovery times, contributing to the popularity of these less invasive techniques, which are propelling this region's growth.

Key players in the market

Some of the key players in the Varicose Vein Treatment Market include Medtronic PLC, Dornier MedTech GmbH, Candela Medical, Won Tech Co. Ltd, Boston Scientific, Sciton Inc., El. En SpA Group, Alma Lasers Ltd, Teleflex Incorporated, AngioDynamics Inc., Eufoton SRL and Biolitec AG

Key Developments:

In December 2023, Teleflex Incorporated announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex's Peripheral Access products.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) have approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension.

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain.

Products Covered:

  • Venous Closure Products
  • Ablation Devices
  • Surgical Products
  • Other Products

Treatment Types Covered:

  • Surgical Ligation/Stripping
  • Endovenous Ablation
  • Injection Sclerotherapy
  • Other Treatment Types

End Users Covered:

  • Vein Clinics
  • Ambulatory Care Unit
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Varicose Vein Treatment Market, By Product

  • 5.1 Introduction
  • 5.2 Venous Closure Products
  • 5.3 Ablation Devices
    • 5.3.1 Radiofrequency Ablation Devices
    • 5.3.2 Laser Ablation Devices
  • 5.4 Surgical Products
  • 5.5 Other Products

6 Global Varicose Vein Treatment Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Surgical Ligation/Stripping
  • 6.3 Endovenous Ablation
  • 6.4 Injection Sclerotherapy
  • 6.5 Other Treatment Types

7 Global Varicose Vein Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Vein Clinics
  • 7.3 Ambulatory Care Unit
  • 7.4 Hospitals
  • 7.5 Other End Users

8 Global Varicose Vein Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Medtronic PLC
  • 10.2 Dornier MedTech GmbH
  • 10.3 Candela Medical
  • 10.4 Won Tech Co. Ltd
  • 10.5 Boston Scientific
  • 10.6 Sciton Inc.
  • 10.7 El. En SpA Group
  • 10.8 Alma Lasers Ltd
  • 10.9 Teleflex Incorporated
  • 10.10 AngioDynamics Inc.
  • 10.11 Eufoton SRL
  • 10.12 Biolitec AG